Treatment of posttransplantation diabetes mellitus with anti-CD20 monoclonal antibodies

被引：0
|
作者：
Vandenbosch, K [1 ]
Champagne, MA [1 ]
Gonthier, M [1 ]
Moghrabi, A [1 ]
Vachon, MF [1 ]
Duval, M [1 ]
机构：
[1] Hop St Justine, Montreal, PQ H3T 1C5, Canada
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.192
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
192
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [41] IRF8 regulates efficacy of therapeutic anti-CD20 monoclonal antibodies
    Grzelak, Ludivine
    Roesch, Ferdinand
    Vaysse, Amaury
    Biton, Anne
    Legendre, Rachel
    Porrot, Francoise
    Commere, Pierre-Henri
    Planchais, Cyril
    Mouquet, Hugo
    Vignuzzi, Marco
    Bruel, Timothee
    Schwartz, Olivier
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 (10) : 1648 - 1661
  • [42] Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises
    Bagacean, Cristina
    Zdrenghea, Mihnea
    Tempescul, Adrian
    Cristea, Victor
    Renaudineau, Yves
    IMMUNOTHERAPY, 2016, 8 (05) : 569 - 581
  • [43] Dynamics of TREC and KREC for patients after therapy with anti-CD20 monoclonal antibodies
    Polyakova, Ekaterina
    Stegantseva, Maria
    Uglova, Tatyana
    Belevtsev, Mikhail
    CLINICAL IMMUNOLOGY, 2023, 250 : 97 - 97
  • [44] Rituximab, ofatumumab and other monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia
    Bauer, Kathrin
    Rancea, Michaela
    Roloff, Verena
    Elter, Thomas
    Hallek, Michael
    Engert, Andreas
    Skoetz, Nicole
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (11):
  • [45] Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies
    Winiarska, Magdalena
    Bojarczuk, Kamil
    Pyrzynska, Beata
    Bil, Jacek
    Siernicka, Marta
    Dwojak, Michal
    Bobrowicz, Malgorzata
    Miazek, Nina
    Zapala, Piotr
    Zagozdzon, Agnieszka
    Krol, Magdalena
    Syta, Aleksandra
    Podszywalow-Bartnicka, Paulina
    Pilch, Zofia
    Dabrowska-Iwanicka, Anna
    Juszczynski, Przemyslaw
    Efremov, Dimitar G.
    Slabicki, Mikolaj
    Zenz, Thorsten
    Le Roy, Aude
    Olive, Daniel
    Rygiel, Tomasz P.
    Leusen, Jeanette H. W.
    Golab, Jakub
    MABS, 2014, 6 (05) : 1300 - 1313
  • [46] All anti-CD20 monoclonal antibodies have similar efficacy and risks: Commentary
    Dimaandal, Ian
    Imitola, Jaime
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (12) : 1847 - 1848
  • [47] Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies
    R. O. Dillman
    Clinical and Experimental Medicine, 2006, 6
  • [48] Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies
    Dillman, RO
    CLINICAL AND EXPERIMENTAL MEDICINE, 2006, 6 (01) : 1 - 12
  • [49] Recurrent Idiopathic Membranous Nephropathy: Early Diagnosis by Protocol Biopsies and Treatment with Anti-CD20 Monoclonal Antibodies
    El-Zoghby, Ziad M.
    Grande, Joseph P.
    Fraile, M. G.
    Norby, S. M.
    Fervenza, F. C.
    Cosio, F. G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (12) : 2800 - 2807
  • [50] Anti-CD20 monoclonal antibody in autoimmune diseases
    Pogliani, EM
    Larocca, A
    BIOMEDICINE & PHARMACOTHERAPY, 2002, 56 (07) : 350 - 351
12345